Outcomes of UM171 CB Cohort and CIBMTR CB Controls. (A-B) Kaplan-Meier estimates of OS (A) and progression-free survival (B). (C) GRFS by Kaplan-Meier estimate of the UM171 CB cohort (UM171) appears superior to that of the CIBMTR CB controls (UCB) when compared with log-rank test. (D) Cumulative incidence of NRM of the UM171 CB cohort is lower than that of the CIBMTR CB controls when compared by Gray test.